ACET 2 15 MG — DIN 00706515
CODEINE PHOSPHATE : 15 MG ACETAMINOPHEN : 300 MG CAFFEINE : 15 MG · PHARMASCIENCE INC · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is ACET 2?
ACET 2 15 MG contains CODEINE PHOSPHATE : 15 MG ACETAMINOPHEN : 300 MG CAFFEINE : 15 MG. It is listed in the Health Canada Drug Product Database under DIN 00706515, held by PHARMASCIENCE INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 09-May-2013. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Codeine And Paracetamol cost around the world?
Codeine And Paracetamol is listed on 19 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Brazil | preco fabrica (ex-factory ceiling) | 50 | 203 | BRL███.██ |
| South Africa | single exit price | 132 | 188 | ZAR███.██ |
| Saudi Arabia | public | 128 | 150 | SAR███.██ |
| Bahrain | retail (max) | 72 | 126 | BHD███.██ |
| Spain | PVP con IVA (public price) | 116 | 117 | EUR███.██ |
| Australia | ex-manufacturer | 25 | 105 | AUD███.██ |
| Morocco | PPV (public price) | 23 | 71 | MAD███.██ |
| Sweden | AIP (pharmacy purchase price) | 19 | 63 | SEK███.██ |
| Norway | max AUP (pharmacy retail) | 16 | 55 | NOK███.██ |
| Luxembourg | reimbursement | 46 | 46 | EUR███.██ |
| United Arab Emirates | public | 28 | 34 | AED███.██ |
| United Kingdom | hospital | 24 | 24 | GBP███.██ |
| Belgium | public | 22 | 22 | EUR███.██ |
| Austria | KVP (Kassenverkaufspreis) | 8 | 10 | EUR███.██ |
| Greece | producer price (ex-factory) | 5 | 5 | EUR███.██ |
| Romania | max producer price | 3 | 4 | RON███.██ |
| Lebanon | public price (USD, Decision 119/1) | 1 | 3 | USD███.██ |
| Czechia | max producer price (ex-factory) | 1 | 2 | CZK███.██ |
| Hungary | producer price (ex-factory) | 1 | 2 | HUF███.██ |
1230 pack listings across 720 brand entries and 16 price bases, refreshed 08 Sep 2026. Ranges span every Codeine And Paracetamol pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Codeine And Paracetamol in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
22 holders have a Canadian DIN containing Codeine And Paracetamol, across 66 DINs, of which 9 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 6 | 6 | ACETAMINOPHEN WITH CODEINE - CAPLET, TEVA-EMTEC-30, TEVA-LENOLTEC NO. 1, TEVA-LENOLTEC NO. 2, TEVA-LENOLTEC NO. 3, +1 more | Sourceable in Canada |
| LABORATOIRE RIVA INC. | 6 | 2 | ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE TABLETS, ACETAMINOPHENE CODEINE ET CAFEINE CAPLETS, ACETAMINOPHENE CODEINE ET CAFEINE FORT, TRIATEC-30, TRIATEC-8, +1 more | Sourceable in Canada |
| PHARMASCIENCE INC | 14 | 1 | ACET 2, ACET 3, ACET CODEINE 30, ACET CODEINE 60, ACETAMINOPHEN 500 MG COMPOUND TABLETS WITH CODEINE, +8 more | Sourceable in Canada |
| CELLCHEM PHARMACEUTICALS INC. | 4 | 0 | ACETAMINOPHEN 500MG, CAFFEINE AND 8MG CODEINE PHOSPHATE, ACETAMINOPHEN, CAFFEINE AND 8 MG OF CODEINE PHOSPHATE TABLETS, ACETAMINOPHEN, CAFFEINE, AND 8MG OF CODEINE PHOSPHATE TABLETS, MUSCLE AND BACK PAIN RELIEF - 8 TABLETS | No marketed DIN |
| JANSSEN INC | 4 | 0 | TYLENOL WITH CODEINE ELIXIR, TYLENOL WITH CODEINE NO. 2 - TAB, TYLENOL WITH CODEINE NO. 3 - TAB, TYLENOL WITH CODEINE NO. 4 | No marketed DIN |
| NOVOPHARM LIMITED | 4 | 0 | ACETAMINOPHEN CAFFEINE & 8MG COD. PHOS. TAB, NOVO-GESIC C15, NOVO-GESIC C30, NOVO-GESIC-C8 | No marketed DIN |
| CHURCH & DWIGHT CANADA CORP | 3 | 0 | ATASOL 15, ATASOL 30, ATASOL 8 | No marketed DIN |
| MCNEIL PHARMACEUTICAL, DIVISION OF ORTHO-MCNEIL INC. | 3 | 0 | TYLENOL NO 1 TAB, TYLENOL NO1 FORTE TABLETS WITH CODEINE, TYLENOL WITH CODEINE ELIXIR | No marketed DIN |
| MERCK FROSST CANADA & CIE, MERCK FROSST CANADA & CO. | 3 | 0 | EXDOL 15TAB, EXDOL 30TAB, EXDOL 8 TAB | No marketed DIN |
| GLAXOSMITHKLINE INC | 2 | 0 | EMPRACET-30, EMPRACET-60 | No marketed DIN |
| JAMP PHARMA CORPORATION | 2 | 0 | ACETAMINOPHEN ELIXIR WITH 8MG CODEINE PHOSPHATE SYRUP, ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE TABLETS | No marketed DIN |
| STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | 2 | 0 | (EXTRA STRENGTH) ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE CAPLETS, ACETAMINOPHEN CAFFEINE & 8MG COD PHOS TAB | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 15 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Codeine And Paracetamol |
|---|---|
| ATC code | N02AJ06 |
| AHFS class | 28:08.08 ; 28:08.92 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00706515 |
|---|---|
| DIN (unpadded, as printed on some documents) | 706515 |
| Brand name | ACET 2 |
| Generic / active ingredient | CODEINE PHOSPHATE : 15 MG ACETAMINOPHEN : 300 MG CAFFEINE : 15 MG |
| Market authorization holder | PHARMASCIENCE INC |
| Health Canada schedule | NARCOTICS (CDSA I) |
| ATC code | N02AJ06 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N02AJ |
| Current status | CANCELLED POST MARKET |
| Status date | 09-May-2013 |
| Original market date | 1994-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
9 of 66 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACETAMINOPHEN WITH CODEINE - CAPLET | 300 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 02143933 |
| ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE TABLETS | 300 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED | 02154234 |
| PMS-ACETAMINOPHEN WITH CODEINE ELIXIR | 8 MG / 5 ML | ELIXIR | PHARMASCIENCE INC | MARKETED | 00816027 |
| TEVA-EMTEC-30 | 30 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 00608882 |
| TEVA-LENOLTEC NO. 1 | 15 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 00653233 |
| TEVA-LENOLTEC NO. 2 | 15 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 00653241 |
| TEVA-LENOLTEC NO. 3 | 300 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 00653276 |
| TEVA-LENOLTEC NO. 4 | 60 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 00621463 |
| TRIATEC-30 | 300 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED | 00789828 |
| (EXTRA STRENGTH) ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE CAPLETS | 15 MG | TABLET | STANLEY PHARMACEUTICALS, A DIVISION OF VITA HEALTH PRODUCTS INC. | CANCELLED POST MARKET | 02236871 |
2 · Same class — other molecules in ATC N02AJ
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Codeine And Paracetamol | (EXTRA STRENGTH) ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE CAPLETS · ACET 2 · ACET 3 · ACET CODEINE 30 · +60 more | 66 | 9 | Yes |
| Tramadol And Paracetamol | ACT TRAMADOL/ACET · AG-ACET-TRAMADOL · APO-TRAMADOL/ACET · AURO-TRAMADOL/ACETAMINOPHEN · +20 more | 24 | 8 | Yes |
| Oxycodone And Paracetamol | APO-OXYCODONE/ACET · ENDOCET · NTP-OXYCODONE ACETAMINOPHEN · NU-OXYCODONE/ACET · +10 more | 14 | 3 | Yes |
| Oxycodone And Acetylsalicylic Acid | ENDODAN · PERCODAN · PERCODAN-DEMI · RIVACODAN · +1 more | 5 | 1 | Yes |
| Codeine And Acetylsalicylic Acid | 222 TABLETS · 282 TAB · 282 TABLETS · 292 TAB · +21 more | 26 | 0 | Not in Canada |
| Hydrocodone And Ibuprofen | CODOFEN · IBUCODONE | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N02AA | Codein, Combinations With Psycholeptics · Codeine, Combinations Excl. Psycholeptics · Hydromorphone · Morphine · Natural Opium Alkaloids · +3 more | 378 | 129 |
| N02AX | Tapentadol · Tramadol | 41 | 30 |
| N02AB | Fentanyl · Pethidine | 105 | 17 |
| N02AE | Buprenorphine | 15 | 4 |
| N02AF | Butorphanol · Nalbufine | 5 | 2 |
| N02AC | Dextropropoxyphene · Dextropropoxyphene, Comb Excl Psycholept | 7 | 0 |
| N02AD | Pentazocine | 3 | 0 |
| N02AG | Opioids In Comb With Antispasmodics | 3 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is ACET 2 called?
The same molecule, Codeine And Paracetamol, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Paracetamol | Latin | Brazil, Lebanon, South Africa |
| TYLENOL | Latin | Bahrain, Brazil |
| DOLIPRANE | Latin | Morocco |
| Citodon® | Latin | Sweden |
| ADOL | Latin | Bahrain, Saudi Arabia |
| PARANTAL | Latin | Morocco |
| Paralgin Forte | Latin | Norway |
| Altermol | Latin | Norway, Sweden |
| CETAMYL | Latin | Morocco |
| Omol | Latin | Bahrain, Saudi Arabia |
| Paracetamol/Kodein Evolan | Latin | Sweden |
| Tensodol | Latin | South Africa |
| Alvedon® | Latin | Sweden |
| APO-Paracetamol | Latin | Australia |
| Febridol | Latin | Australia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Acetaminophen called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Acetaminophen, published to help those searches reach this page.
| Language | Acetaminophen |
|---|---|
| Russian Русский | ацетаминофен |
| Spanish Español | paracetamol |
| French Français | paracétamol |
| Portuguese Português | paracetamol |
| German Deutsch | Acetaminophen |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.